

Prof José-Manuel Carrascosa
Professor José-Manuel Carrascosa-Carrillo is the Head of the Department of Dermatology, Hospital Universitario Germans Trias i Pujol, Universitat Autònoma de Barcelona, Spain, and has been Associate Professor at the Universitat Autònoma de Barcelona since 2009. He earned his medical degree at the Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona, in 1991 and his PhD degree at the Universitat Autònoma de Barcelona in 2006.
Professor Carrascosa-Carrillo is responsible for the Psoriasis, Phototherapy/Photobiology, Contact Dermatitis and Eczema Department and the Psoriasis Unit at the Hospital Universitario Germans Trias i Pujol. He has been Principal Investigator/Clinical Investigator in more than 60 research projects/clinical trials, many of them multinational, multicentre studies related to biological therapies in psoriasis and atopic dermatitis.
Professor Carrascosa-Carrillo has authored or co-authored 214 articles in journals on dermatology or other medical specialties. He was Editor-in-Chief of Actas Dermo-sifiliográficas from 2010 to 2014 and is currently a reviewer for several peer-reviewed journals, including Journal of Investigative Dermatology, The Lancet, Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of Crohn's and Colitis, Journal of Dermatological Science and Biodrugs. He has been Chairperson at more than 100 local and international meetings and has been invited to give more than 250 lectures (national/ international) at conferences, symposia and other events. Professor Carrascosa is the Chair of the Spanish Group of Psoriasis of the Spanish Academy of Dermatology and vice-president of the Academia Española de Dermatología y Venereología (AEDV). Moreover, he has been a member of the scientific board of the Skin Inflammation & Psoriasis International Network (SPIN) since 2015 and was on the organising committee of the 2019 and 2022 SPIN meetings in Paris. He has been recently elected as a councillor of the International Psoriasis Council (IPC).

Use of imaging in HS management
Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation

Evidence-based approach to medical management based on the European guidelines for HS
Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy

Informed decisions for effective HS management
Different HS phenotypes and disease severity scores: their role in informing management decisions

The role of surgery in HS management: Optimising patient results
Surgical management of HS, through minor procedures to more complex interventions

Recognising HS symptoms: Diagnosis and what you need to know
Key criteria for diagnosing HS, common misdiagnoses and how AI can be used to assess disease severity

Taking a holistic approach: HS and its comorbidities
HS often presents with comorbidities extending beyond the skin. A holistic approach is essential for effective HS management